🇺🇸 FDA
Patent

US 12427125

Method for treating SARS and treating or preventing ARDS

granted A61KA61K31/167A61K31/19

Quick answer

US patent 12427125 (Method for treating SARS and treating or preventing ARDS) held by Aardvark Therapeutics, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aardvark Therapeutics, Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/167, A61K31/19, A61K31/192, A61K31/215